Know Cancer

or
forgot password

Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation


N/A
18 Years
N/A
Not Enrolling
Both
Liver Neoplasms

Thank you

Trial Information

Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation


An estimated 75 patients (age 18 years of age or older) will be enrolled from the population
of patients who present for ultrasound-guided radiofrequency ablation (RFA) of CT or
MRI-confirmed multiple primary hepatocellular carcinoma (HCC) or metastatic carcinoma, with
at least one of the tumors being ≤ 1.5 cm in diameter.


Inclusion Criteria:



- Patients with primary hepatocellular carcinoma (HCC) or secondary (metastatic)
carcinoma of the liver who have been referred for ultrasound-guided radiofrequency
ablation (RFA) treatment

- Recent (within 90 days) CT or MRI scan with report of one or more tumors ≤ 1.5 cm in
diameter

- Patient is stable and is to be managed conservatively (i.e. non-surgically)

- 18 years of age or older

- Ability and willingness to provide written informed consent

Exclusion Criteria:

- Known or suspected cardiac shunt(s)

- Known sensitivity to octafluoropropane

- Pregnant or breastfeeding

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

estimation of the the increase in conspicuity of small intrahepatic tumors with contrast-enhanced sonography

Outcome Time Frame:

3 years

Safety Issue:

No

Principal Investigator

John P. McGahan, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

UC Davis School of Medicine Dept. of Radiology

Authority:

United States: Institutional Review Board

Study ID:

200715241

NCT ID:

NCT00584402

Start Date:

April 2007

Completion Date:

March 2009

Related Keywords:

  • Liver Neoplasms
  • liver cancer
  • Neoplasms
  • Liver Neoplasms

Name

Location

UC Davis Medical CenterSacramento, California  95817